Publication | Open Access

Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia

HemodialysisUrologyRecombinant ErythropoietinHemodialysis PatientsRenal FunctionMedicineKidney FailureHematologyDialysis TherapyChronic Kidney DiseaseNephrologyIntravenous Ascorbic Acid